Page 1 | Search Results | Diabetes | American Diabetes Association

1-17 of 17

Sort by

Sort Order Select

Meeting Abstracts

179-OR: Improved A1C and TIR with Once-Weekly Insulin Icodec vs. Insulin Glargine U100 in Insulin-Naïve T2D—ONWARDS 1

JULIO ROSENSTOCK, STEPHEN C. BAIN, AMOOLYA GOWDA, HIROSHI HORIO, ESTEBAN JODAR, LARS LANG LEHRSKOV, ILDIKO LINGVAY, ROBERTO TREVISAN, OFRI MOSENZON

Diabetes 2023;72(Supplement_1):179-OR

https://doi.org/10.2337/db23-179-OR

Published: 24 June 2023

View article titled, 179-OR: Improved A1C and TIR with Once-Weekly Insulin Icodec vs. Insulin Glargine U100 in Insulin-Naïve T2D—ONWARDS 1

Meeting Abstracts

1823-PUB: Expanded Dataset Improves Accuracy of Wrist-Worn Noninvasive BGM Using AI

MOHAMED S. CHAUDHRY, MUHAMMAD R.A. QURESHI, STEPHEN C. BAIN, STEPHEN D. LUZIO, CONSUELO M. HANDY, BRAD LOVE, NUNO M.M. SILVA, LUIS M. FERREIRA, KATHIE WAREHAM, GARETH J. DUNSEATH, JULIA RYAN, LUCY BARLOW, ISAMAR C. CARRILLO MASSO, JOEL H. CRANE

Diabetes 2023;72(Supplement_1):1823-PUB

https://doi.org/10.2337/db23-1823-PUB

Published: 23 June 2023

View article titled, 1823-PUB: Expanded Dataset Improves Accuracy of Wrist-Worn Noninvasive BGM Using AI

Meeting Abstracts

664-P: Incorporating Treatment Pauses, Dosing Flexibility, and Education to Support GLP-1RA Therapy Persistence

VANITA R. ARODA, ROBERT BAUER, ALUN L. DAVIES, ESKIL B. KREINER, PETER J. LIN, RICHARD E. PRATLEY, STEPHEN C. BAIN

Diabetes 2021;70(Supplement_1):664-P

https://doi.org/10.2337/db21-664-P

Published: 01 June 2021

View article titled, 664-P: Incorporating Treatment Pauses, Dosing Flexibility, and Education to Support GLP-1RA Therapy Persistence

Meeting Abstracts

660-P: Greater Proportions of Subjects Achieved Composite Endpoints with Once-Weekly Semaglutide vs. Comparators in SUSTAIN Trials

PETER GÆDE, ANDREI-MIRCEA CATARIG, KATHLEEN M. DUNGAN, CHARLOTTE HINDSBERGER, JENS ØLLGAARD, STEPHEN C. BAIN

Diabetes 2021;70(Supplement_1):660-P

https://doi.org/10.2337/db21-660-P

Published: 01 June 2021

View article titled, 660-P: Greater Proportions of Subjects Achieved Composite Endpoints with Once-Weekly Semaglutide vs. Comparators in SUSTAIN Trials

Meeting Abstracts

278-OR: Efficacy and Safety of Anti-interleukin (IL)-21 in Combination with Liraglutide in Adults Recently Diagnosed with Type 1 Diabetes

MATTHIAS G. VON HERRATH, STEPHEN C. BAIN, BRUCE W. BODE, JESPER OLE CLAUSEN, KEN COPPIETERS, LEYLYA GAYSINA, JANUSZ GUMPRECHT, TROELS K. HANSEN, CHANTAL MATHIEU, CRISTOBAL MORALES PORTILLO, OFRI MOSENZON, STINE SEGEL, GEORGE M. TSOUKAS, THOMAS PIEBER

Diabetes 2020;69(Supplement_1):278-OR

https://doi.org/10.2337/db20-278-OR

Published: 01 June 2020

View article titled, 278-OR: Efficacy and Safety of Anti-interleukin (IL)-21 in Combination with Liraglutide in Adults Recently Diagnosed with Type 1 Diabetes

Meeting Abstracts

296-OR: Diminished Sensor Performance of the Abbott Freestyle Libre Intermittently-Viewed Continuous Glucose Monitoring System (ICGMS) during Hypoglycemia and Acute Exercise in People with Type 1 Diabetes

OTHMAR MOSER, MAX L. ECKSTEIN, OLIVIA MCCARTHY, RACHEL DEERE, JASON PITT, DAVID M. WILLIAMS, JENNIFER HAYES, STEPHEN C. BAIN, RICHARD M. BRACKEN

Diabetes 2019;68(Supplement_1):296-OR

https://doi.org/10.2337/db19-296-OR

Published: 01 June 2019

View article titled, 296-OR: Diminished Sensor Performance of the Abbott Freestyle Libre Intermittently-Viewed Continuous Glucose Monitoring System (ICGMS) during Hypoglycemia and Acute Exercise in People with Type 1 Diabetes

Meeting Abstracts

Effects of IDegLira (Insulin Degludec/Liraglutide) in Patients with Poorly Controlled Type 2 Diabetes (T2D) with A1C >9%—Analyses from the DUAL Program

DANNY SUGIMOTO, JUAN P. FRIAS, DIDIER GOUET, RÓBERT TAKÁCS, TING JIA, PETRA ÖRSY, STEPHEN C. BAIN

Diabetes 2018;67(Supplement_1):1092-P

https://doi.org/10.2337/db18-1092-P

Published: 01 July 2018

View article titled, Effects of IDegLira (Insulin Degludec/Liraglutide) in Patients with Poorly Controlled Type 2 Diabetes (T2D) with A1C >9%—Analyses from the DUAL Program

Meeting Abstracts

Use of Insulin Degludec in Type 1 Diabetes Clinical Practice in the U.K.—General Practice Data from Two English Regions and Data from the Association of British Clinical Diabetologists (ABCD) Nationwide Degludec Audit

ALISTAIR N. LUMB, IAN W. GALLEN, ALEX BICKERTON, RALPH R. ABRAHAM, STEPHEN C. BAIN, ROY HARPER, ROBERT E. RYDER, ABCD NATIONWIDE DEGLUDEC AUDIT CONTRIBUTORS

Diabetes 2018;67(Supplement_1):2291-PUB

https://doi.org/10.2337/db18-2291-PUB

Published: 01 July 2018

View article titled, Use of Insulin Degludec in Type 1 Diabetes Clinical Practice in the U.K.—General Practice Data from Two English Regions and Data from the Association of British Clinical Diabetologists (ABCD) Nationwide Degludec Audit

Meeting Abstracts

Consistent HbA1c and Body Weight Reduction with Semaglutide Independent of Diabetes Duration—SUSTAIN 1-5 and 7 Patient-Level Meta-analysis

JULIO ROSENSTOCK, LOUIS B. CHAYKIN, JOERG LUEDEMANN, STEN MADSBAD, SR., JULIE F. LARSEN, EMRE YILDIRIM, STEPHEN C. BAIN

Diabetes 2018;67(Supplement_1):1081-P

https://doi.org/10.2337/db18-1081-P

Published: 01 July 2018

View article titled, Consistent HbA1c and Body Weight Reduction with Semaglutide Independent of Diabetes Duration—SUSTAIN 1-5 and 7 Patient-Level Meta-analysis

Meeting Abstracts

Efficacy and Safety of Dapagliflozin in Patients with Inadequately Controlled Type 1 Diabetes—DEPICT-2 Study

CHANTAL MATHIEU, PARESH DANDONA, PIETER GILLARD, PETER A. SENIOR, CHRISTOPH HASSLACHER, EIICHI ARAKI, MARCUS LIND, STEPHEN C. BAIN, SERGE JABBOUR, NIKI ARYA, FREDRIK A. THOREN, ANNA MARIA LANGKILDE, ON BEHALF OF THE DEPICT-2 INVESTIGATORS

Diabetes 2018;67(Supplement_1):213-OR

https://doi.org/10.2337/db18-213-OR

Published: 01 July 2018

View article titled, Efficacy and Safety of Dapagliflozin in Patients with Inadequately Controlled Type 1 Diabetes—DEPICT-2 Study

Meeting Abstracts

Liraglutide Effects in Insulin-Treated Patients in LEADER

CORNELIS TACK, STEPHAN JACOB, CYRUS DESOUZA, STEPHEN C. BAIN, MICHAEL A. NAUCK, JOHN PETRIE, NEIL R. POULTER, RICHARD E. PRATLEY, HELEN VANYA BIERING KJAER STEGMANN, HEIDRUN BOSCH-TRABERG, ELENA STARTSEVA, BERNARD ZINMAN, LEADER PUBLICATION COMMITTEE & INVESTIGATORS

Diabetes 2018;67(Supplement_1):438-P

https://doi.org/10.2337/db18-438-P

Published: 01 July 2018

View article titled, Liraglutide Effects in Insulin-Treated Patients in LEADER

Journal Articles

The HLA-DPB1–Associated Component of the IDDM1 and Its Relationship to the Major Loci HLA-DQB1, -DQA1, and -DRB1

Francesco Cucca, Frank Dudbridge, Miriam Loddo, Anna P. Mulargia, Rosannna Lampis, Efisio Angius, Stefano De Virgiliis, Bobby P.C. Koeleman, Stephen C. Bain, Anthony H. Barnett, Frances Gilchrist, Heather Cordell, Ken Welsh, John A. Todd

Diabetes 2001;50(5):1200–1205

https://doi.org/10.2337/diabetes.50.5.1200

Published: 01 May 2001

View article titled, The HLA-DPB1–Associated Component of the IDDM1 and Its Relationship to the Major Loci HLA-DQB1, -DQA1, and -DRB1

Journal Articles

Association of Apolipoprotein ε2 Allele With Diabetic Nephropathy in Caucasian Subjects With IDDM

Tahseen A Chowdhury, Philip H Dyer, Sudesh Kumar, Simon P Gibson, Bethan R Rowe, Simon J Davies, Sally M Marshall, Peter J Morris, Geoffrey V Gill, Susan Feeney, Peter Maxwell, David Savage, Andrew J M Boulton, John A Todd, David Dunger, Anthony H Barnett, Stephen C Bain

Diabetes 1998;47(2):278–280

https://doi.org/10.2337/diab.47.2.278

Published: 01 February 1998

View article titled, Association of Apolipoprotein ε2 Allele With Diabetic Nephropathy in Caucasian Subjects With IDDM

Journal Articles

Mutations in the Hepatocyte Nuclear Factor–1α Gene Are a Common Cause of Maturity-Onset Diabetes of the Young in the U.K.

Timothy M Frayling, Michael P Bulman, Sian Ellard, Maggie Appleton, Mark J Dronsfield, Alasdair D R Mackie, Joyce D Baird, Pamela J Kaisaki, Kazuya Yamagata, Graeme I Bell, Stephen C Bain, Andrew T Hattersley

Diabetes 1997;46(4):720–725

https://doi.org/10.2337/diab.46.4.720

Published: 01 April 1997

View article titled, Mutations in the Hepatocyte Nuclear Factor–1α Gene Are a Common Cause of Maturity-Onset Diabetes of the Young in the U.K.

Journal Articles

Altered Insulin Secretory Responses to Glucose in Diabetic and Nondiabetic Subjects With Mutations in the Diabetes Susceptibility Gene MODY3 on Chromosome 12

Maria M Byrne, Jeppe Sturis, Stephan Menzel, Kazuya Yamagata, Stefan S Fajans, Mark J Dronsfield, Stephen C Bain, Andrew T Hattersley, Gilberto Velho, Phillipe Froguel, Graeme I Bell, Kenneth S Polonsky

Diabetes 1996;45(11):1503–1510

https://doi.org/10.2337/diab.45.11.1503

Published: 01 November 1996

View article titled, Altered Insulin Secretory Responses to Glucose in Diabetic and Nondiabetic Subjects With Mutations in the Diabetes Susceptibility Gene MODY3 on Chromosome 12

Journal Articles

Parental Origin of Diabetes-Associated HLA Types in Sibling Pairs With Type I Diabetes

Stephen C Bain, Bethan R Rowe, Anthony H Barnett, John A Todd

Diabetes 1994;43(12):1462–1468

https://doi.org/10.2337/diab.43.12.1462

Published: 01 December 1994

View article titled, Parental Origin of Diabetes-Associated HLA Types in Sibling Pairs With Type I Diabetes

Journal Articles

A Practical Approach to Identification of Susceptibility Genes for IDDM

John A Todd, Stephen C Bain

Diabetes 1992;41(9):1029–1034

https://doi.org/10.2337/diab.41.9.1029

Published: 01 September 1992

View article titled, A Practical Approach to Identification of Susceptibility Genes for IDDM

NARROW

179-OR: Improved A1C and TIR with Once-Weekly Insulin Icodec vs. Insulin Glargine U100 in Insulin-Naïve T2D—ONWARDS 1

1823-PUB: Expanded Dataset Improves Accuracy of Wrist-Worn Noninvasive BGM Using AI

664-P: Incorporating Treatment Pauses, Dosing Flexibility, and Education to Support GLP-1RA Therapy Persistence

660-P: Greater Proportions of Subjects Achieved Composite Endpoints with Once-Weekly Semaglutide vs. Comparators in SUSTAIN Trials

278-OR: Efficacy and Safety of Anti-interleukin (IL)-21 in Combination with Liraglutide in Adults Recently Diagnosed with Type 1 Diabetes

296-OR: Diminished Sensor Performance of the Abbott Freestyle Libre Intermittently-Viewed Continuous Glucose Monitoring System (ICGMS) during Hypoglycemia and Acute Exercise in People with Type 1 Diabetes

Effects of IDegLira (Insulin Degludec/Liraglutide) in Patients with Poorly Controlled Type 2 Diabetes (T2D) with A1C >9%—Analyses from the DUAL Program

Use of Insulin Degludec in Type 1 Diabetes Clinical Practice in the U.K.—General Practice Data from Two English Regions and Data from the Association of British Clinical Diabetologists (ABCD) Nationwide Degludec Audit

Consistent HbA1c and Body Weight Reduction with Semaglutide Independent of Diabetes Duration—SUSTAIN 1-5 and 7 Patient-Level Meta-analysis

Efficacy and Safety of Dapagliflozin in Patients with Inadequately Controlled Type 1 Diabetes—DEPICT-2 Study

Liraglutide Effects in Insulin-Treated Patients in LEADER

The HLA-DPB1–Associated Component of the IDDM1 and Its Relationship to the Major Loci HLA-DQB1, -DQA1, and -DRB1

Association of Apolipoprotein ε2 Allele With Diabetic Nephropathy in Caucasian Subjects With IDDM

Mutations in the Hepatocyte Nuclear Factor–1α Gene Are a Common Cause of Maturity-Onset Diabetes of the Young in the U.K.

Altered Insulin Secretory Responses to Glucose in Diabetic and Nondiabetic Subjects With Mutations in the Diabetes Susceptibility Gene MODY3 on Chromosome 12

Parental Origin of Diabetes-Associated HLA Types in Sibling Pairs With Type I Diabetes

A Practical Approach to Identification of Susceptibility Genes for IDDM

Email alerts

Journals

Books

Clinical Compendia

News

Other

About

Resources

Email alerts

Journals

Books

Clinical Compendia

News

Other

About

Resources

This Feature Is Available To Subscribers Only